Added to YB: 2026-01-07
Pitch date: 2026-01-02
IRIX [neutral]
IRIDEX Corporation
+0.85%
current return
Author Info
Trident Opportunities writes about deep value and special situation investment opportunities. Sign up for the newsletter.
Company Info
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Market Cap
$20.1M
Pitch Price
$1.18
Price Target
N/A
Dividend
N/A
EV/EBITDA
-14.71
P/E
-3.86
EV/Sales
0.50
Sector
Health Care Equipment and Supplies
Category
turnaround
Trident Opportunities | Portfolioupdate Q4 - 2025 - +24.8% - IRIDEX Corporation
IRIX (reduced position): Medical device co in turnaround w/ razor-blade model (probes at 80% gross margin). Mgmt expects Q4 rev growth, 2026 EBIT & FCF positive. Cost cuts: facility move saves $270-300k/qtr, offshore staff. Clinical studies driving 8-12% probe growth. Insider buys $120k. Author reduced position post-earnings but rebuilding on turnaround progress.
Read full article (3 min)